Broad-spectrum antibiotic

Revision as of 19:02, 27 September 2011 by WikiBot (talk | contribs) (Protected "Broad-spectrum antibiotic": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite)))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

WikiDoc Resources for Broad-spectrum antibiotic

Articles

Most recent articles on Broad-spectrum antibiotic

Most cited articles on Broad-spectrum antibiotic

Review articles on Broad-spectrum antibiotic

Articles on Broad-spectrum antibiotic in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Broad-spectrum antibiotic

Images of Broad-spectrum antibiotic

Photos of Broad-spectrum antibiotic

Podcasts & MP3s on Broad-spectrum antibiotic

Videos on Broad-spectrum antibiotic

Evidence Based Medicine

Cochrane Collaboration on Broad-spectrum antibiotic

Bandolier on Broad-spectrum antibiotic

TRIP on Broad-spectrum antibiotic

Clinical Trials

Ongoing Trials on Broad-spectrum antibiotic at Clinical Trials.gov

Trial results on Broad-spectrum antibiotic

Clinical Trials on Broad-spectrum antibiotic at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Broad-spectrum antibiotic

NICE Guidance on Broad-spectrum antibiotic

NHS PRODIGY Guidance

FDA on Broad-spectrum antibiotic

CDC on Broad-spectrum antibiotic

Books

Books on Broad-spectrum antibiotic

News

Broad-spectrum antibiotic in the news

Be alerted to news on Broad-spectrum antibiotic

News trends on Broad-spectrum antibiotic

Commentary

Blogs on Broad-spectrum antibiotic

Definitions

Definitions of Broad-spectrum antibiotic

Patient Resources / Community

Patient resources on Broad-spectrum antibiotic

Discussion groups on Broad-spectrum antibiotic

Patient Handouts on Broad-spectrum antibiotic

Directions to Hospitals Treating Broad-spectrum antibiotic

Risk calculators and risk factors for Broad-spectrum antibiotic

Healthcare Provider Resources

Symptoms of Broad-spectrum antibiotic

Causes & Risk Factors for Broad-spectrum antibiotic

Diagnostic studies for Broad-spectrum antibiotic

Treatment of Broad-spectrum antibiotic

Continuing Medical Education (CME)

CME Programs on Broad-spectrum antibiotic

International

Broad-spectrum antibiotic en Espanol

Broad-spectrum antibiotic en Francais

Business

Broad-spectrum antibiotic in the Marketplace

Patents on Broad-spectrum antibiotic

Experimental / Informatics

List of terms related to Broad-spectrum antibiotic

Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

The term broad-spectrum antibiotic refers to an antibiotic with activity against a wide range of disease-causing bacteria. This is in contrast to a narrow-spectrum antibiotic which is effective against only specific families of bacteria. A good example of a commonly used broad-spectrum antibiotic is levofloxacin.

Uses

Broad-spectrum antibiotics are properly used in the following medical situations:

  • Empirically prior to identifying the causative bacteria when there is a wide differential and potentially serious illness would result in delay of treatment. This occurs, for example, in meningitis, where the patient can become so ill that he/she could die within hours if broad-spectrum antibiotics are not initiated.
  • In super-infections where there are multiple types of bacteria causing illness, thus warranting either a broad-spectrum antibiotic or combination antibiotic therapy.

There has been a common usage of broad-spectrum agents in treatment of community acquired infections without attempting to culture or otherwise identify the causative bacteria. Over the years, this practice has contributed to the emergence of more drug resistant strains of bacteria, necessitating the development of newer broad-spectrum antibiotics.

Ideally, the spectrum should be "narrowed down" by identifying the causative agent of an infection, and then replacing the broad-spectrum antibiotic with an appropriate narrower-spectrum antibiotic. This is believed to limit the development of antibiotic resistance, although evidence for this practice is unclear.

Examples

In medicine, amoxycillin, levofloxacin. In veterinary medicine, Co-amoxiclav (e.g. Synulox, from Pfizer) (in small animals); penicillin & streptomycin (e.g. Streptacare from Animalcare Ltd) and oxytetracycline (in farm animals); penicillin and potentiated sulphonamides (e.g. Equitrim, Boehringer) (in horses).

See also

Template:SIB


Template:WS